CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

ontamalimab

mAbexperimental

Clinical trial activity

8 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
7
Phase 3
7
Phase 4
0

Earliest trial started Oct 31, 2017 (NCT03259308)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07052682Phase 1Jan 18, 2023Takeda
NCT03627091Phase 3Nov 30, 2018Shire
NCT03559517Phase 3Jun 25, 2018Shire
NCT03566823Phase 3Jun 11, 2018Shire
NCT03290781Phase 3Apr 4, 2018Shire
NCT03283085Phase 3Feb 27, 2018Shire
NCT03259334Phase 3Nov 9, 2017Shire
NCT03259308Phase 3Oct 31, 2017Shire
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ShireFor profit7712017
TakedaFor profit1112023
2 organizations
Page 1 / 1